Artificial intelligence models accurately predicted non-transplantable recurrence in hepatocellular carcinoma patients post-hepatic resection. An ensemble AI model showed high accuracy (AUC 0.751-0.858) with incorporation of postoperative factors. Radiologic tumor burden and microvascular invasion were key predictors. Patients with predicted recurrence had lower survival rates, highlighting the models’ prognostic value. The AI models could guide treatment decisions and personalize postoperative care for better outcomes.
Journal Article by Altaf A, Endo Y (…) Pawlik TM et 17 al. in HPB (Oxford)
Copyright © 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.